The US FDA Committee ‘Hearing’ Is Dead! Long Live The Committee Hearing!
Executive Summary
The US FDA is free from the need to reconsider Accelerated Approvals in a formal hearing in front of an advisory committee. But now the agency is now trying that approach to hear an appeal of a rejected application.